HAL (France)open access
Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signaling
0, 2, Therapy, Microbiology, Anti-inflammatory, Antiviral, Pneumonia, Influenza Virus
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 391961
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.